• The University of Western Australia (M704), 35 Stirling Highway,

    6009 Perth


Calculated based on number of publications stored in Pure and citations from Scopus

Personal profile


Medical degree (MBBS) St Mary’s Hospital, London 1994; Basic Surgical Training in London (FRCS (Eng) 1998). Research Fellow University College London - doctorate in medicine (MD) 2003. Specialist Training West Midlands, UK (FRCS Urol) 2006. FRACS 2011

Roles and responsibilities

Professor Dickon Hayne is a clinical academic who leads urological research and education in urology, at the University of Western Australia. He works as consultant urological surgeon and is the Head of Urology for the South Metropolitan Health Service, WA. He is Chair of the Bladder, Urothelial and Penile (BUP) Cancer Sub-committee of the Australian & New Zealand Urogenital & Prostate Cancer Trials Group (ANZUP), an SAC member, leads the BCGMM trial and is widely engaged in other sub-committees, trials and activities of ANZUP.  His major clinical and research interests are urological cancer, in particular bladder cancer.

Future research

Sequential BCG and mitomycin intra-vesical therapy versus BCG alone for high-risk non-muscle invasive bladder cancer (NMIBC): 2 stage randomized phase III trial. Accrual complete (n=501) in follow up.

Sub-urothelial injection of immune therapeutic agents - SUBDUE-1 completed in write up. SUBDUE -2 deferred. SUBDUE-3 in development

Funding overview


 June 2022                               Valar Labs 

                                                 Identification of BCG Unresponsive NMIBC

                                                 Small grant (8k) for initial collaborration


 April 2022                               WACPCN Special Grants

                                                Addressing Inequalities Facing West Australians with Bladder Cancer

                                                 $44896.29 Project supervisor


Octber 2021                            ANZUP 'Below the Belt'

                                                Exploratory Translational work for BCGMM trial



October 2021                          WACPCN Cancer Fellowship

                                                Shifting the Curve - Translating Contemporary Trials for Improved Bladder Cancer Survival

                                                TRanslational work for BCGMM and SUBDUE trials

                                                Approx value $200000 Co-supervisor 


May 2021                                 Telix Pharmaceuticals unrestricted II grant for ZipUp Trial



December 2020                       Cancer Council WA

                                                Telex trial - RCT telehealth vs clinic based weight loss program for overweight prostate cancer pts

                                                 $472739 (CIA Prof D Galvao CID Prof D Hayne)

 November 2019                       Spinnaker Health Research Foundation

                                                 SUBDUE-1 Translational work



 July 2019                                 ANZUP ‘Below the Belt Research Fund’

                                                SUBDUE-1 SUB-urothelial DUrvalumab InjEction – 1


                                                Dickon Hayne and Andrew Moe


July 2019                                 WACPCN Special Grants

OPTIMAL CARE PATHWAYS – Implementation grant Robotic Surgery



Dec 2018                                 NHMRC

BCG+MM Trial: Adding mitomycin to BCG as adjuvant intravesical therapy for high-risk, non–muscle-invasive bladder cancer: a 2-stage, randomised phase 3 trial

5 year funding $1,587,163.80 until 2023 (Funds to complete trial)

CIA Professor Dickon Hayne



Nov 2017                                 NHMRC

                                                Can Exercise Delay Transition to Active Therapy in Men with Low Grade Prostate Cancer? A Multi-Centre Randomized Controlled Trial

                                                5 year funding $596,083.90 until Dec 2022

                                                CIA Daniel Galvao (ECU)

                                                CIE Professor Dickon Hayne



July 2017                                 ANZUP ‘Below the Belt Research Fund’

                                                ‘ANZUP co-operative multi-centre cystectomy database’


                                                Sole recipient


July 2017                                 ANZUP ‘Below the Belt Research Fund’

‘Exercise Medicine Prior to Open Radical Cystectomy: Feasibility and Preliminary Efficacy’


                                                Dennis Taafe and Dickon Hayne



December 2015                        Cancer Australia (Nationally Competitive via NHMRC)

                                                Developing a patient-reported symptom index for non-muscle invasive bladder cancer

$466,317, start date 30 June 2016

                                                CIA Associate Professor Manish Patel

                                                CIC Professor Dickon Hayne



June 2015                                WACPCN Special Grants

                                                Project title: Advancing Cystectomy Care: an Enhanced recovery Pathway Trial (ACCEPT)

                                                $18,000 for one year –seeding funding

                                                Dr Dwayne Chan and Professor Dickon Hayne




Jan 2015                                 University of Sydney Bridging Support Grant 2015

                                                NHMRC Project Grant: APP1080786: OPTIMUM: Optimising Perioperative Therapy in Muscle invasive Urothelial Malignancy. A phase 3 trial of cisplatin and gemcitabine (CG) vs accelerated MVAC (accMVAC) given before or after cystectomy

                                                $30,000 for 1 year

                                                CIA Professor Martin Stockler

                                                CIB Professor Ian Davis

                                                CIC Professor Dickon Hayne

                                                CID Associate Professor Shomik Sengupta

                                                CIE Professor Howard Gurney

                                                CIF Dr Andrew Martin

                                                CIG Dr Sonia Yip



Nov 2014                                 Cancer Australia (Nationally Competitive via NHMRC)

                                                A phase 3, double-blind, placebo-controlled, randomised trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal, ultrasound-guided prostate biopsy

                                                $597,095 for 3 yrs

                                                CIA Professor Ian Davis

                                                CIB Dr Jeremy Grummet

                                                CIC Dr Venu Chalasani

                                                CID Professor Martin Stockler

                                                CIE Dr Andrew Martin

                                                CIF Professor Dickon Hayne

                                                CIG Henry Woo

                                                CIH Mark Frydenberg

                                                CII Colin O’Brien


Sept 2013                                 Cancer and Palliative Care Research and Evaluation Unit (CAPREU)

                                                Delays in presentation to the 'One Stop Haematuria Clinic' at Fremantle Hospital: a study of reasons for delay, and introduction of strategies to combat the only cancer in Australia with deteriorating survival',

                                                $20000 for 12 months

                                                Dr Steve McCombie and Professor Dickon Hayne



Jan 2013                                  Cancer Australia (Nationally Competitive via NHMRC)

Adding MMC to BCG for high-risk non-muscle invasive bladder cancer: a randomised phase 3 trial

                                                $457,143.17 for 3 years commencing 2013

                                                Administering Institution University of Sydney

                                                CIA Professor Dickon Hayne

                                                CIB Associate Professor Manish Patel

                                                CIC Associate Professor Martin Stockler

                                                CID Associate Professor Damien Bolton

                                                CIE Associate Professor Mark Frydenberg

                                                CIF Doctor Venu Chalasani

                                                CIG Mr Mark Chatfield

                                                CIH Miss Amy Boland

                                                CII Professor Ian Davis

                                                CIJ Mr Shomik Sengupta


Nov 2012                                 Fremantle Hospital Research Foundation

                                                ‘Penile Cancer in WA’

                                                $15000 for 1 year

                                                Dr Kevin McMillan

                                                Professor Lyn Fritschi,

                                                Dr David Sofield,

                                                Ms Cynthia Hawks,

                                                Professor Dickon Hayne (Project Lead)



Nov 2012                                 Cancer and Palliative Care Research and Evaluation Unit (CAPREU)

Investigation to determine evidence of bladder cancer stage migration as recorded by the WA Cancer Registry for the periods (1982-1986), (2000-2004) and (2007-2011

$17 500 for 1 year

Prof. Dickon Hayne (PI)

Prof. Lyn Fritschi,

Dr Callum Logan,

Cynthia Hawks


Nov 2010                                 NHMRC

                                                PROCARE trial -A phase II trial of follow-up of men with prostate cancer in primary care

                                                $564410.4 for 3 years
Administering institution: University of Western Australia

CIA: Prof Jon Emery

CIB: A/Prof Penelope Schofield

CIC: A/Prof Michael Jefford

CID: Prof Madeleine Kin,

CIE: Dr Marie Pirotta

CIF: Prof Dickon Hayne

CIG: Dr Andrew Martin

CIH: A/Prof Lyndal Trevena




Oct 2010                                  Prostate Cancer Foundation of Australia

                                                Clinical Equipment Grant for bone densitometer


Professor Robert U. Newton,

Professor Daniel Galvão,

Professor Nigel Spry,

Professor David Joseph,

Dr Richard Prince,

Professor Dickon Hayne,

Dr Prue Cormie


July 2009                                 UWA Faculty Teaching and Learning Committee

                                                General Surgery Web based Learning Modules

                                                $6000 for 1 year

                                                Professor Dickon Hayne (Project Lead)

                                                Mr Khaled Dawas (University College London)

                                                Associate Professor Diana Jonas-Dwyer (Medical Education)

                                                Ms Fiona Leece (Project Officer E-Learning)


Nov 2008                                 UWA Faculty of Medicine, Dentistry and Health Sciences

                                                 Seeding Funding

                                                $20000  for 3 years

                                                Professor Dickon Hayne



July 2008                                 Faculty Teaching and Learning Committee

                                                Urology Web Based Learning Modules

                                                Professor Dickon Hayne (Project Lead)

                                                Dr Wei Ling Ooi

                                                Associate Professor Diana Jonas-Dwyer

                                                Ms Fiona Leece

                                                $5000 for 1 year


Mar 2008                                 WA Cancer & Palliative Care Network

                                                ‘One Stop Haematuria Clinic’ Clinical equipment grant / seeding funding


                                                Prof. Dickon Hayne



Industrial relevance

Consultancy and Advisory Board Abbott Australia

GlaxoSmithKline: Speaker Meetings and Education


Urological oncology. I seek to advance research into urological cancers (particular bladder and prostate cancer) drawing upon my clinical and research based experience in minimally invasive surgery and medical technology, treatment related morbidity, cancer epidemiology and cancer service provision.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Research expertise keywords

  • Urological malignancy
  • Outcomes research/epidemiology
  • Radiation injury
  • Bladder Cancer


Dive into the research topics where Dickon Hayne is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or